These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19181339)

  • 21. Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer.
    Govaert GA; Oostenbroek RJ; Plaisier PW
    Eur J Surg Oncol; 2005 May; 31(4):373-5. PubMed ID: 15837042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of prolonged injection site mass with methylene blue but not isosulfan blue after the sentinel node procedure.
    Shirah GR; Bouton ME; Komenaka IK
    Arch Surg; 2011 Feb; 146(2):137-41. PubMed ID: 21339422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anaphylactic reaction to patent blue in sentinel node biopsy].
    Galatius H; Holtveg HM; Følsgård SL
    Ugeskr Laeger; 2003 Aug; 165(34):3242-3. PubMed ID: 12970997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
    Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
    Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why certain dyes are useful for localizing the sentinel lymph node.
    Tsopelas C; Sutton R
    J Nucl Med; 2002 Oct; 43(10):1377-82. PubMed ID: 12368377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaphylactic reaction to patent blue V after sentinel lymph node biopsy.
    Dewachter P; Mouton-Faivre C; Benhaijoub A; Abel-Decollogne F; Mertes PM
    Acta Anaesthesiol Scand; 2006 Feb; 50(2):245-7. PubMed ID: 16430550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy assessment using intraoperative imprint cytology in breast cancer patients: results of a validation study.
    Deo S; Samaiya A; Jain P; Asthana S; Anand M; Shukla NK; Kumar R
    Asian J Surg; 2004 Oct; 27(4):294-8. PubMed ID: 15564182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer.
    Mullan MH; Deacock SJ; Quiney NF; Kissin MW
    Eur J Surg Oncol; 2001 Mar; 27(2):218-9. PubMed ID: 11289765
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospective comparison of peritumoral and subareolar injection of blue dye alone, for identification of sentinel lymph nodes in patients with early stage breast cancer.
    Kaklamanos IG; Birbas K; Syrigos K; Bonatsos VG; Bonatsos G
    J Surg Oncol; 2011 Jul; 104(1):37-40. PubMed ID: 21360537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the gamma probe guided sentinel lymph node biopsy and the blue dye technique in the management of breast cancer.
    Usmani S; Khan HA; abu Huda F; Ahmed N; al Nafisi N; Marafi F; al Mohannadi S; Javed A; Amanguno HG; Al Saleh N
    Hell J Nucl Med; 2010; 13(1):30-4. PubMed ID: 20411168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blue hives localized to the opposite arm after patent blue v injection for lymph node mapping in breast cancer.
    Olsha O; Carmon M
    Breast J; 2005; 11(6):468. PubMed ID: 16297094
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical efficacy of sentinel lymph node biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma.
    Ji YB; Lee KJ; Park YS; Hong SM; Paik SS; Tae K
    Ann Surg Oncol; 2012 Jun; 19(6):1868-73. PubMed ID: 21989668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blue dye of choice for lymphatic mapping.
    Vargas HI
    J Clin Oncol; 2005 May; 23(15):3648; author reply 3648-9. PubMed ID: 15908691
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immediate patent blue-induced hypersensitivity during sentinel node detection: The value of cutaneous tests].
    Jeudy G; Louvier N; Rapennes T; Goujon E; Fraisse J; Dalac-Rat S; Collet E
    Ann Dermatol Venereol; 2008; 135(6-7):461-5. PubMed ID: 18598795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced ultrasound-guided Sentinel lymph node biopsy of the ocular conjunctiva.
    Rabinowitz MR; Merton DA; Liu JB; Saxena S; Pluta J; Eisenbrey JR; Baker AL; Rabinowitz MP; Lally S; Cognetti D; Goldberg BB; Pribitkin EA; Curry JM
    Laryngoscope; 2014 Nov; 124(11):2531-6. PubMed ID: 24925374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of sentinel lymph node biopsy in early breast cancer.
    Patel NS; Sisodia VK; Vadher SH
    J Indian Med Assoc; 2014 Feb; 112(2):110-2. PubMed ID: 25935968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isosulfan blue-induced anaphylactic reaction during sentinel lymph node biopsy in breast cancer.
    Cinar H; Koca B; Kesicioglu T; Karabulut K; Karabicak I; Polat C; Tur AH
    Breast; 2012 Apr; 21(2):220-2. PubMed ID: 22186354
    [No Abstract]   [Full Text] [Related]  

  • 38. Concordance between peri-areolar blue dye and peri-incisional radiotracer injections for sentinel node mapping in patients with a history of primary breast cancer excisonal biopsy.
    Mehrabibahar M; Azizi S; Jangjoo A; Saremi E; Kakhki VR; Sadeghi R; Chicken DW; Keshtgar M
    Acta Chir Belg; 2014; 114(1):31-3. PubMed ID: 24720135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node biopsy in early breast cancer surgery--working with the risks of vital blue dye to reap the benefits.
    White V; Harvey JR; Griffith CD; Youssef M; Carr M
    Eur J Surg Oncol; 2011 Feb; 37(2):101-8. PubMed ID: 21195576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy.
    Bleicher RJ; Kloth DD; Robinson D; Axelrod P
    J Surg Oncol; 2009 May; 99(6):356-60. PubMed ID: 19189298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.